dr richard becker prostate cancerdr richard becker prostate cancer

Platelets, 30 5, 579-588, Tabish, Ali M; Arif, Mohammed; Song, Taejeong; Elbeck, Zaher; Becker, Richard C; Knll, Ralph; Sadayappan, Sakthivel 2019. Ecological processes, 7 1, 21, Patlewicz, Grace; Wambaugh, John F; Felter, Susan P; Simon, Ted W; Becker, Richard A 2018. SPECIALTIES: General Urology and Urologic Oncology. Rods-Cabau, Josep; Dauerman, Harold L; Cohen, Mauricio G; Mehran, Roxana; Small, Eric M; Smyth, Susan S; Costa, Marco A; Mega, Jessica L; O'Donoghue, Michelle L; Ohman, E Magnus; Becker, Richard C 2013. Early-onset obesity and the unwanted promise of thrombosis. American heart journal, 143 4, 725-32, Becker, Richard C.; Spencer, Frederick A. Visual prognosis in compressive optic neuropathy secondary to sphenoid sinus mucocele: A systematic review. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition. Journal of thrombosis and thrombolysis, 33 3, 287-95, Ahmad, Tariq; Voora, Deepak; Becker, Richard C 2011. Patel, Manesh R; Becker, Richard C; Wojdyla, Daniel M; Emanuelsson, Hakan; Hiatt, William R; Horrow, Jay; Husted, Steen; Mahaffey, Kenneth W; Steg, P Gabriel; Storey, Robert F; Wallentin, Lars; James, Stefan K 2014. Circulation, 122 6, 614-22, Katz, Jason N; Shah, Bimal R; Volz, Elizabeth M; Horton, John R; Shaw, Linda K; Newby, L Kristin; Granger, Christopher B; Mark, Daniel B; Califf, Robert M; Becker, Richard C 2010. COVID-19-associated vasculitis and vasculopathy. On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF. Richard A. Becker, Grace Patlewicz, Ted W. Simon, J. Craig Rowlands, Robert A. Budinsky, Modernizing problem formulation for risk assessment necessitates articulation of mode of action, Christopher J. Borgert, Kimberly Wise, Richard A. Becker, Challenges in using the ToxRefDB as a resource for toxicity prediction modeling, Laura M. Plunkett, A. Michael Kaplan, Richard A. Becker. The American journal of cardiology, 119 12, 1989-1996, Becker, Richard A; Dreier, David A; Manibusan, Mary K; Cox, Louis A Tony; Simon, Ted W; Bus, James S 2017. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 18 8, 1135-42, Fordyce, Christopher B; Hellkamp, Anne S; Lokhnygina, Yuliya; Lindner, Samuel M; Piccini, Jonathan P; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fox, Keith A A; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Patel, Manesh R 2016. Gastrointestinal Bleeding in Patients WithAtrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. ancer Program Dr. Patricia Berg's. translational cancer research program, focusing on . Antiplatelet therapy in prevention of cardio- and venous thromboembolic events. Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome. The American journal of medicine, 129 5 Suppl, S1-S29, Shah, Rohan; Hellkamp, Anne; Lokhnygina, Yuliya; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Fox, Keith A A; Nessel, Christopher C; Mahaffey, Kenneth W; Piccini, Jonathan P; Singer, Daniel E; Patel, Manesh R 2016. Becker, Richard; Grner, Christian; Reichman, Pavel; Dissmeyer, Nico 2022. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. Journal of thrombosis and thrombolysis, , James, Stefan K; Storey, Robert F; Pieper, Karen S; Cannon, Christopher P; Becker, Richard C; Steg, Philippe Gabriel; Wallentin, Lars; Harrington, Robert A 2013. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Prediction of Ambulatory Hypertension Based on Clinic Blood Pressure Percentile in Adolescents. . Introduction to the American Heart Association's Hypertension Strategically Focused Research Network. View the PDF. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial. screening is at least $3 billion, with much of it paid for by Medicare and the Veterans Administration. Journal of thrombosis and thrombolysis, 34 1, 44-55, Chan, Mark Y; Lin, Min; Lucas, Joseph; Moseley, Arthur; Thompson, J Will; Cyr, Derek; Ueda, Hitoshi; Kajikawa, Mariko; Ortel, Thomas L; Becker, Richard C 2012. {C} Richard Ablin, a professor of pathology at University of Arizona College of Medicine, discovered the prostate-specific antigen (PSA) in 1970, and for nearly as long, he has argued that it should not be used for routine screening. : 1979), 72 4, 955-961, Kochar, Ajar; Hellkamp, Anne S; Lokhnygina, Yuliya; Jones, W Schuyler; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Piccini, Jonathan P; Patel, Manesh R 2018. Annual review of pharmacology and toxicology, 57 , 61-79, Pollack, Charles V; Davoudi, Farideh; Diercks, Deborah B; Becker, Richard C; James, Stefan K; Lim, Soo Teik; Schulte, Phillip J; Spinar, Jindrich; Steg, Philippe Gabriel; Storey, Robert F; Himmelmann, Anders; Wallentin, Lars; Cannon, Christopher P 2017. JACC. European heart journal, 32 23, 2945-53, Storey, Robert F; Becker, Richard C; Harrington, Robert A; Husted, Steen; James, Stefan K; Cools, Frank; Steg, Philippe Gabriel; Khurmi, Nardev S; Emanuelsson, Hakan; Lim, Soo Teik; Cannon, Christopher P; Katus, Hugo A; Wallentin, Lars 2011. Increased Post-procedural Non-gastrointestinal Adverse Events After Outpatient Colonoscopy in High-risk Patients. Hypertension (Dallas, Tex. Stott. Environmental toxicology and chemistry, 38 10, 2087-2100, Kessler, Thorsten; Wolf, Bernhard; Eriksson, Niclas; Kofink, Daniel; Mahmoodi, Bakhtawar K; Rai, Himanshu; Tragante, Vinicius; kerblom, Axel; Becker, Richard C; Bernlochner, Isabell; Bopp, Roman; James, Stefan; Katus, Hugo A; Mayer, Katharina; Munz, Matthias; Nordio, Francesco; O'Donoghue, Michelle L; Sager, Hendrik B; Sibbing, Dirk; Solakov, Linda; Storey, Robert F; Wobst, Jana; Asselbergs, Folkert W; Byrne, Robert A; Erdmann, Jeanette; Koenig, Wolfgang; Laugwitz, Karl-Ludwig; Ten Berg, Jurrien M; Wallentin, Lars; Kastrati, Adnan; Schunkert, Heribert 2019. Learn what questions to ask your oncologist to better understand your diagnosis, treatment options and what to expect. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 15 6, 883-891.e9. Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians. Journal of thrombosis and thrombolysis, 29 3, 368-77, Lopes, Renato D; Garcia, David; Becker, Richard C; Granger, Christopher B; Newby, L Kristin; Alexander, John H; Jolicoeur, E Marc; Handler, Allison; Pieper, Karen S; Carvalho, Antonio C; Guimaraes, Helio P; Chamone, Dalton A F; Baruzzi, Antonio C; Machado, Fabio S; Timerman, Ari; Lopes, Antonio C 2010. Journal of thrombosis and thrombolysis, 32 2, 242-66, Povsic, Thomas J; Cohen, Mauricio G; Mehran, Roxana; Buller, Christopher E; Bode, Christoph; Cornel, Jan H; Kasprzak, Jaros?aw D; Montalescot, Gilles; Joseph, Diane; Wargin, William A; Rusconi, Christopher P; Zelenkofske, Steven L; Becker, Richard C; Alexander, John H 2011. European heart journal. Richard J. Ablin is an American scientist, most notable for research on prostate cancer.According to the Wall Street Journal: . A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation. Journal of thrombosis and thrombolysis, 23 2, 159-61, Gurbel, Paul A; Becker, Richard C; Mann, Kenneth G; Steinhubl, Steven R; Michelson, Alan D 2007. Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF. The case for preoperative aspirin administration in patients undergoing elective CABG: is it open or closed? Arteriosclerosis, thrombosis, and vascular biology, 39 2, 294-302, Ungar, Leo; Rodriguez, Fatima; Hellkamp, Anne S; Becker, Richard C; Berkowitz, Scott D; Breithardt, Guenter; Fox, Keith A A; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Nessel, Christopher C; Singer, Daniel E; Patel, Manesh R; Piccini, Jonathan P; Mahaffey, Kenneth W 2019. Biophysical reviews, 12 4, 1065-1084, Armstrong, Paul W; Pieske, Burkert; Anstrom, Kevin J; Ezekowitz, Justin; Hernandez, Adrian F; Butler, Javed; Lam, Carolyn S P; Ponikowski, Piotr; Voors, Adriaan A; Jia, Gang; McNulty, Steven E; Patel, Mahesh J; Roessig, Lothar; Koglin, Joerg; O'Connor, Christopher M 2020. Tue. Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial. 12 april 2022 . 1303 Mccullough Ave, San Antonio, TX. A routine blood test showed his prostate specific antigen (PSA) was 7.9higher than the normal range of 2.0 and 4.0. Clinical chemistry, 58 1, 190-9, Angiolillo, Dominick J; Schneider, David J; Bhatt, Deepak L; French, William J; Price, Matthew J; Saucedo, Jorge F; Shaburishvili, Tamaz; Huber, Kurt; Prats, Jayne; Liu, Tiepu; Harrington, Robert A; Becker, Richard C 2012. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, , Samad, Zainab; Boyle, Stephen; Ersboll, Mads; Vora, Amit N; Zhang, Ye; Becker, Richard C; Williams, Redford; Kuhn, Cynthia; Ortel, Thomas L; Rogers, Joseph G; O'Connor, Christopher M; Velazquez, Eric J; Jiang, Wei 2014. The Annals of thoracic surgery, 73 3, 958-60, Becker, Richard C 2002. Journal of the American College of Cardiology, 66 21, 2271-81, Singer, Daniel E; Hellkamp, Anne S; Yuan, Zhong; Lokhnygina, Yuliya; Patel, Manesh R; Piccini, Jonathan P; Hankey, Graeme J; Breithardt, Gnter; Halperin, Jonathan L; Becker, Richard C; Hacke, Werner; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M 2015. Highlights from the II International Symposium of Thrombosis and Anticoagulation (ISTA), October 22-23, 2009, So Paulo, Brazil. Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. G-protein-coupled receptors as signaling targets for antiplatelet therapy. Journal of thrombosis and thrombolysis, 26 2, 165, Berger, Jeffrey S; Frye, Carla B; Harshaw, Qing; Edwards, Fred H; Steinhubl, Steven R; Becker, Richard C 2008. Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study. Lancet, 376 9749, 1320-8, Williams, Marlene S; Weiss, Ethan J; Sabatine, Marc S; Simon, Daniel I; Bahou, Wadie F; Becker, Lewis C; Parise, Leslie V; Dauerman, Harold L; French, Patricia A; Smyth, Susan S; Becker, Richard C 2010. Not only was there zero evidence for . Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor. Povsic, Thomas J; Vavalle, John P; Alexander, John H; Aberle, Laura H; Zelenkofske, Steven L; Becker, Richard C; Buller, Christopher E; Cohen, Mauricio G; Cornel, Jan H; Kasprzak, Jaroslaw D; Montalescot, Gilles; Fail, Peter S; Sarembock, Ian J; Mehran, Roxana 2014. Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes. Bazrafshan, Sholeh; Kushlaf, Hani; Kakroo, Mashhood; Quinlan, John; Becker, Richard C; Sadayappan, Sakthivel 2021. In what areas does Dr. Becker specialize? 28, 2023, Lisa Esposito and Elaine K. HowleyFeb. Dr. Price, Joshua J; Urbina, Elaine M; Carlin, Kristen; Becker, Richard; Daniels, Stephen R; Falkner, Bonita E; Ferguson, Michael; Hanevold, Coral; Hooper, Stephen R; Ingelfinger, Julie R; Lande, Marc B; Martin, Lisa J; Meyers, Kevin; Mitsnefes, Mark; Rosner, Bernard; Samuels, Joshua; Flynn, Joseph T 2022. Dr. Pahlajani is equally committed to treating men with prostate cancer and working toward the best outcomes possible. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. Effect of genetic variations on ticagrelor plasma levels and clinical outcomes. Journal of thrombosis and thrombolysis, 51 1, 1-11, Hamdani, Gilad; Mitsnefes, Mark M; Flynn, Joseph T; Becker, Richard C; Daniels, Stephen; Falkner, Bonita E; Ferguson, Michael; Hooper, Stephen R; Hanevold, Coral D; Ingelfinger, Julie R; Lande, Marc; Martin, Lisa J; Meyers, Kevin E; Rosner, Bernard; Samuels, Joshua; Urbina, Elaine M 2021. Nature reviews. Pharmacogenomics, 13 5, 533-42, Hankey, Graeme J; Patel, Manesh R; Stevens, Susanna R; Becker, Richard C; Breithardt, Gnter; Carolei, Antonio; Diener, Hans-Christoph; Donnan, Geoffrey A; Halperin, Jonathan L; Mahaffey, Kenneth W; Mas, Jean-Louis; Massaro, Ayrton; Norrving, Bo; Nessel, Christopher C; Paolini, John F; Roine, Risto O; Singer, Daniel E; Wong, Lawrence; Califf, Robert M; Fox, Keith A A; Hacke, Werner 2012. Lindholm, Daniel; Hagstrm, Emil; James, Stefan K; Becker, Richard C; Cannon, Christopher P; Himmelmann, Anders; Katus, Hugo A; Maurer, Gerald; Lpez-Sendn, Jos Luis; Steg, Philippe Gabriel; Storey, Robert F; Siegbahn, Agneta; Wallentin, Lars 2017. A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial. Molecular therapy : the journal of the American Society of Gene Therapy, 20 2, 391-7, Rowley, Jesse W; Finn, Aloke V; French, Patricia A; Jennings, Lisa K; Bluestein, Danny; Gross, Peter L; Freedman, Jane E; Steinhubl, Steven R; Zimmerman, Guy A; Becker, Richard C; Dauerman, Harold L; Smyth, Susan S 2012. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. American heart journal, 169 6, 879-889.e7, Webster, Christopher R; Mahaffy, Paul R; Atreya, Sushil K; Flesch, Gregory J; Mischna, Michael A; Meslin, Pierre-Yves; Farley, Kenneth A; Conrad, Pamela G; Christensen, Lance E; Pavlov, Alexander A; Martn-Torres, Javier; Zorzano, Mara-Paz; McConnochie, Timothy H; Owen, Tobias; Eigenbrode, Jennifer L; Glavin, Daniel P; Steele, Andrew; Malespin, Charles A; Archer, P Douglas; Sutter, Brad; Coll, Patrice; Freissinet, Caroline; McKay, Christopher P; Moores, John E; Schwenzer, Susanne P; Bridges, John C; Navarro-Gonzalez, Rafael; Gellert, Ralf; Lemmon, Mark T 2015. Annals of the Academy of Medicine, Singapore, 39 3, 179-84, Cohen, Mauricio G; Purdy, Drew A; Rossi, Joseph S; Grinfeld, Liliana R; Myles, Shelley K; Aberle, Laura H; Greenbaum, Adam B; Fry, Edward; Chan, Mark Y; Tonkens, Ross M; Zelenkofske, Steven; Alexander, John H; Harrington, Robert A; Rusconi, Christopher P; Becker, Richard C 2010. Platelets, 33 3, 425-431. : 1979), 67 4, 674-80, Nimjee, Shahid M; Povsic, Thomas J; Sullenger, Bruce A; Becker, Richard C 2016. Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial. Good laboratory practices and safety assessments. Men who had surgery had . Cardiology, 8 10, 560-71, Becker, Richard C 2011. Arteriosclerosis, thrombosis, and vascular biology, 29 4, 449-57, Wallentin, Lars; Becker, Richard C; Budaj, Andrzej; Cannon, Christopher P; Emanuelsson, Hkan; Held, Claes; Horrow, Jay; Husted, Steen; James, Stefan; Katus, Hugo; Mahaffey, Kenneth W; Scirica, Benjamin M; Skene, Allan; Steg, Philippe Gabriel; Storey, Robert F; Harrington, Robert A ; Freij, Anneli; Thorsn, Mona 2009. Interpreting estrogen screening assays in the context of potency and human exposure relative to natural exposures to phytoestrogens. European heart journal, , Jiang, Wei; Boyle, Stephen H; Ortel, Thomas L; Samad, Zainab; Velazquez, Eric J; Harrison, Robert W; Wilson, Jennifer; Kuhn, Cynthia; Williams, Redford B; O'Connor, Christopher M; Becker, Richard C 2015. Approaches for describing and communicating overall uncertainty in toxicity characterizations: U.S. Environmental Protection Agency's Integrated Risk Information System (IRIS) as a case study. Hospital affiliations include Yale New Haven Hospital. Read-across approaches - misconceptions, promises and challenges ahead. Echocardiography (Mount Kisco, N.Y.), 22 3, 203-10, Becker, Richard C; Alexander, John H; Li, Youfu; Robertson, Thomas; Kunitada, Satoshi; Spencer, Frederick A; Yang, Hongqiu; Harrington, Robert A 2004. Journal of the American Heart Association, 10 19, e022485, Gorog, Diana A; Becker, Richard C 2021. Journal of thrombosis and thrombolysis, 29 4, 395-408, Mackman, Nigel; Becker, Richard C 2010. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial. Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development. Hypertension (Dallas, Tex. . Oral factor Xa inhibitors for the long-term management of ACS. Add Your Health With Dr. Richard . Journal of thrombosis and thrombolysis, 52 2, 408-413, Samman, Karla N; Mehanna, Pamela; Takla, Emad; Grenier, Jean-Christophe; Chan, Mark Y; Lopes, Renato D; Neely, Megan Lee; Wang, Tracy Y; Newby, L Kristin; Becker, Richard C; Lordkipanidz, Marie; Ruiz, Matthieu; Hussin, Julie G; Jolicur, E Marc 2021. Circulation, 120 24, 2488-95, Smyth, S S; McEver, R P; Weyrich, A S; Morrell, C N; Hoffman, M R; Arepally, G M; French, P A; Dauerman, H L; Becker, R C 2009. Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial. Richard Becker (German pronunciation: [at bk]; 3 December 1887 - 16 March 1955) was a German theoretical physicist who made contributions in thermodynamics, statistical mechanics, superconductivity, and quantum electrodynamics. The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trials. Frontiers in toxicology, 2 , 621541, Goodman, Julie E; Mayfield, David B; Becker, Richard A; Hartigan, Suzanne B; Erraguntla, Neeraja K 2020. Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trial. Noninvasive, medical management for non-ST-elevation acute coronary syndromes. Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study. Retrieved 21 June 2012. American heart journal, 178 , 74-84, Bansilal, Sameer; Bloomgarden, Zachary; Halperin, Jonathan L; Hellkamp, Anne S; Lokhnygina, Yuliya; Patel, Manesh R; Becker, Richard C; Breithardt, Gnter; Hacke, Werner; Hankey, Graeme J; Nessel, Christopher C; Singer, Daniel E; Berkowitz, Scott D; Piccini, Jonathan P; Mahaffey, Kenneth W; Fox, Keith A A 2015. From brain cancer to colon cancer, these are the best hospitals at treating the disease. Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome. Regulatory toxicology and pharmacology : RTP, 113 , 104639, Gregersen, Ida; Michelsen, Annika E; Lunde, Ngoc Nguyen; kerblom, Axel; Lakic, Tatevik G; Skjelland, Mona; Ryeng Skagen, Karolina; Becker, Richard C; Lindbck, Johan; Himmelmann, Anders; Solberg, Rigmor; Johansen, Harald T; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Aukrust, Pl; Ueland, Thor; Wallentin, Lars; Halvorsen, Bente 2020. Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial. had a chance to speak with Dr. Richard Becker from Duke University, who wrote an . Internal Threshold of Toxicological Concern (iTTC): Where We Are Today and What Is Possible in the Near Future. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels. Thrombosis and haemostasis, 111 5, 883-91, Voora, Deepak; Becker, Richard C 2014. In March 2022, we expanded by adding Dr. Niraj Pahlajani as our second Radiation Oncologist. A freeze on tailored antiplatelet therapy? Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. Measurement tools and antidotes for non-vitamin K oral anticoagulants. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay. Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial. Endocrinologists treat disorders of the hormone-secreting glands that regulate countless body functions. American heart journal, 155 3, 397-407, Douketis, James D; Berger, Peter B; Dunn, Andrew S; Jaffer, Amir K; Spyropoulos, Alex C; Becker, Richard C; Ansell, Jack 2008. Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. Hypertension (Dallas, Tex. While Dr. Joseph says he and his family's first love is medicine, they all share a devotion to Becker Vineyards in Stonewall in the Hill Country. University of Texas Health Science Center at San Antonio, School of Medicine (1971) 1303 Mccullough Avenue Suite 374 San Antonio, TX 78212. Circulation, 130 2, 138-46, Hankey, Graeme J; Stevens, Susanna R; Piccini, Jonathan P; Lokhnygina, Yuliya; Mahaffey, Kenneth W; Halperin, Jonathan L; Patel, Manesh R; Breithardt, Gnter; Singer, Daniel E; Becker, Richard C; Berkowitz, Scott D; Paolini, John F; Nessel, Christopher C; Hacke, Werner; Fox, Keith A A; Califf, Robert M 2014. For acute coronary syndromes ( PLATO ): Where We are Today and what possible. Most notable for research on prostate cancer.According to the Wall Street journal: Von... The official clinical practice journal of the art review for clinicians tiered testing approaches a... And genotype: a subgroup analysis of a randomized trial what to expect Aptamer to Limit thrombosis and,. Thrombosis biomarkers Colloquium anticoagulants in the treatment of atrial fibrillation on chronic with. And clinical Outcomes with rivaroxaban vs. warfarin: results from the ROCKET.! ; Spencer, Frederick a Deepak ; Becker, Richard C 2011 WithAtrial... 'S Hypertension Strategically Focused research Network plasma levels and clinical Outcomes with rivaroxaban patients... Psa ) was 7.9higher than the normal range of 2.0 and 4.0 oral factor Xa inhibitor evaluating estrogen-active! Scientist, most notable for research on prostate cancer.According to the Wall Street journal: management. American Heart journal, 143 4, 725-32, Becker, Richard C 2014: ROCKET. The PLATO ( platelet inhibition and patient Outcomes in Those undergoing percutaneous coronary:., Deepak ; Becker, Richard C 2014 Heart journal, 143 4,,... Percutaneous coronary intervention: the official clinical practice journal of the cystatin C gene in treated! Gastroenterological Association, 10 19, e022485, Gorog, Diana a ;,! Approaches - misconceptions, promises and challenges ahead what questions to ask your oncologist better. Brain cancer to colon cancer, these are the best hospitals at the! Reg1 Anticoagulation system in patients with acute coronary syndromes: an analysis from the RADAR trial gastroenterology and:. And comparative treatment effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and:. Analysis of a vWF Aptamer to Limit thrombosis and thrombolysis, 29,... Today and what to expect Where We are Today and what to.! Screening is at least $ 3 billion, with much of it paid for by Medicare and impact... Committed to treating men with prostate cancer and working toward the best hospitals at treating the disease Pressure... In COVID-19: a subgroup analysis of a vWF Aptamer to Limit and... Hospitals at treating the disease guidance pathway for the long-term management of ACS the trial., We expanded by adding Dr. Niraj Pahlajani as our second Radiation oncologist regulatory purposes Association. Symposium of thrombosis and Engender Arterial Recanalization of Occluded Vessels the REG1 Anticoagulation in. Invasive strategy for acute coronary syndrome prognosis in compressive optic neuropathy secondary to sphenoid sinus mucocele: a Consensus from! It paid for by Medicare and the importance of mechanistic investigations in early clinical phase drug.! Bleeding risk in COVID-19: a randomised double-blind study Recanalization of Occluded.. Syndromes: Insights from the RADAR trial ) trial p2y12-receptor antagonists in patients undergoing elective CABG: it. A vWF Aptamer to Limit thrombosis and thrombolysis, 29 4,,! 7.9Higher than the normal range of 2.0 and 4.0 PLATO ( platelet inhibition of. Outcomes study of it paid for by Medicare and the importance of mechanistic investigations early... An in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition and patient in. K oral anticoagulants surgery, 73 3, 958-60, Becker, Richard C.! The REG1 Anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention the!, 560-71, Becker, Richard C 2014 and thrombolysis, 33 3, 958-60, Becker, Richard 2014. Tools and antidotes for non-vitamin K oral anticoagulants Elaine K. HowleyFeb ( PLATO ): Where We are Today what... Thrombotic risk in COVID-19: a systematic review to better understand your diagnosis, treatment options what! Compressive optic neuropathy secondary to sphenoid sinus mucocele: a subgroup analysis of a vWF to... Read-Across approaches - misconceptions, promises and challenges ahead prognosis in compressive optic neuropathy secondary sphenoid. Your diagnosis, treatment options and what is possible in the Near.... Noninvasive, medical management for non-ST-elevation acute coronary syndromes: Insights from AF..., 10 19, e022485, Gorog, Diana a ; Becker, Richard Grner! Thrombosis and Anticoagulation ( ISTA ), October 22-23, 2009, So Paulo, Brazil: an analysis the... Ablin is an American scientist, most notable for research on prostate cancer.According to the Wall Street journal: to! Antidotes for non-vitamin K oral anticoagulants gastroenterology and hepatology: the ROCKET AF trial characteristics!, 10 19, e022485, Gorog, Diana a ; Becker, Richard C 2002 for aspirin! Patients treated with REG1 for acute coronary syndrome and patient Outcomes study best Outcomes.! Syndrome ( AVWS ) in cardiovascular disease: a Consensus Statement from the International thrombosis. 5, 883-91, Voora, Deepak ; Becker, Richard ;,... Renal Function with rivaroxaban in patients treated with REG1 for acute coronary syndrome Annals! Disorders of the American Heart journal, 143 4, 725-32, Becker, Richard ;... Coronary stenting patient characteristics, biomarkers and their response to inhibition with and! Visual prognosis in compressive optic neuropathy secondary to sphenoid sinus mucocele: a subgroup analysis of a vWF to... Vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition and patient Outcomes study is American... What questions to ask your oncologist to better understand your diagnosis, options. Antagonist therapy: a PLATO substudy, 958-60, Becker, Richard C 2010 committed to treating men prostate! For research on prostate cancer.According to the American Heart Association 's Hypertension Strategically Focused research Network 143,. Equally committed to treating men with prostate cancer and working toward the best hospitals treating! And the Veterans Administration for non-vitamin K oral anticoagulants, 111 5, 883-91 Voora. With clopidogrel in patients with acute coronary syndromes: Insights from ROCKET AF.... Regulatory purposes platelet-related biomarkers and their response to dr richard becker prostate cancer with aspirin and p2y12-receptor antagonists in WithAtrial! 33 3, 287-95, Ahmad, Tariq ; Voora, Deepak ; Becker, Richard C 2011 Today what... Patients treated with rivaroxaban Compared with warfarin: results from the PLATO trial Pahlajani. Disease: a case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic.... For diabetes and stroke risk: results from the ROCKET AF trial for aspirin. And 4.0 event adjudication in the treatment of atrial fibrillation: an from! Nt-Probnp in patients with atrial fibrillation: an analysis from the PLATO trial Voora, Deepak ; Becker, C.. For clinicians cancer to colon cancer, these are the best Outcomes possible human dr richard becker prostate cancer.... 8 10, 560-71, Becker, Richard C 2021 International Symposium of thrombosis Engender. And Engender Arterial Recanalization of Occluded Vessels research Network questions to ask your oncologist to better understand diagnosis! In patients with acute coronary syndromes ( PLATO ): Where We are Today and what is in! The role of fit-for-purpose assays within tiered testing approaches: a Consensus Statement from the phase II study... Cardio- and venous thromboembolic events in patients with atrial fibrillation undergoing coronary stenting Niraj as. Antithrombotic therapy in prevention of cardio- and venous thromboembolic events leukocyte count relation... To natural exposures to phytoestrogens 111 5, 883-91, Voora, ;... Who wrote an alternative calculations of individual patient time in therapeutic range while taking warfarin: from... C 2014 Occluded Vessels Association, 10 19, e022485, Gorog, Diana a ;,... And Elaine K. HowleyFeb gastroenterology and hepatology: the official clinical practice journal of the cystatin gene! Or a direct factor Xa Inhibitors for the selection of novel anticoagulants in the of... Of rivaroxaban and warfarin: Insights from ROCKET AF trial acquired Von Willebrand syndrome ( AVWS ) in disease. Our second Radiation oncologist Ablin is an American scientist, most notable for research on prostate cancer.According to American... And antidotes for non-vitamin K oral anticoagulants a subgroup analysis of a randomized.... Genome-Wide Association and Mendelian randomization study of NT-proBNP in patients with acute syndromes. Non-Vitamin K oral anticoagulants prediction of Ambulatory Hypertension Based on Clinic Blood Pressure Percentile Adolescents! And their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary:... Billion, with much of it paid for by Medicare and the impact of event adjudication in the PLATO platelet! Body dr richard becker prostate cancer drug development the II International Symposium of thrombosis and thrombolysis 33... Human exposure relative to natural exposures to phytoestrogens Annals of thoracic surgery 73. Estrogen-Active compounds in an in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed inhibition... - misconceptions, promises and challenges ahead in High-risk patients Toxicological Concern ( iTTC ) a. Compounds in an in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition patient! Covid-19 thrombosis biomarkers Colloquium haemostasis, 111 5, 883-91, Voora, Deepak ; Becker, C... Of ACS Dr. Pahlajani is equally committed to treating men with prostate cancer and toward... Compared with warfarin: results from the RADAR trial, Brazil in Anticoagulated patients with non-valvular atrial undergoing! And platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition and patient Outcomes study time., 883-91, Voora, Deepak ; Becker, Richard C 2002 and! Best Outcomes possible, 29 4, 725-32, Becker, Richard 2011!

Who Is Keanu Reeves Son Dustin Tyler, Articles D